Evidence map›Paper›PMID 42625845›Full record

ArticleReproductive medicine and biology

Clinical Appraisal of "Micronized Vaginal Progesterone Dose and Serum Progesterone Thresholds Determine Reproductive Outcomes in Frozen-Thawed Embryo Transfer With Hormone Replacement Therapy".

I-Hsuan Wu, Juan-Enrique Schwarze, Christoph Helwig, Thomas D'Hooghe, Ilka Schellschmidt

Abstract readComment
In one paragraph

Article in Reproductive medicine and biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

I-Hsuan WuMerck Healthcare KGaA Darmstadt Germany.ORCID https://orcid.org/0009-0006-4429-396X
Juan-Enrique SchwarzeMerck Healthcare KGaA Darmstadt Germany.
Christoph HelwigMerck Healthcare KGaA Darmstadt Germany.ORCID https://orcid.org/0000-0003-4916-9918
Thomas D'HoogheGlobal Medical Affairs Fertility, Research and Development, Merck Healthcare KGaA Darmstadt Germany.
Ilka SchellschmidtMerck Healthcare KGaA Darmstadt Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper critically evaluates Sekiguchi et al.'s study of vaginal progesterone dose, serum progesterone thresholds, and reproductive outcomes in hormone replacement therapy frozen embryo transfer (HRT-FET) cycles. The study conflates descriptive, predictive, and causal aims without a clearly prespecified primary question, limiting interpretability. Major concerns include non-random treatment allocation, potential residual confounding, absence of a causal framework for covariate selection, unaddressed temporal confounding related to Japan's 2022 insurance reform, and exclusion of an available progesterone formulation. Additionally, formulation specific pharmacokinetics, single-time-point progesterone measurement, and internally derived thresholding limit comparability, predictive validity, and clinical applicability.

Identifiers

PMID42625845
PMCPMC13490851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.